JAK2, CALR, MPL and ASXL1 mutational status correlates with distinct histological features in Philadelphia chromosome-negative myeloproliferative neoplasms

Similar Items

• JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms
  od: Shirane, Shuichi, i dr.
  Izdano: (2015)
• Characterization and Prognosis Significance of JAK2 (V617F), MPL, and CALR Mutations in Philadelphia-Negative Myeloproliferative Neoplasms
  od: Singdong, Roongrudee, i dr.
  Izdano: (2016)
• JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms
  od: Ana Isabel Giraldo-Rincón, i dr.
  Izdano: (2023)
• The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms
  od: Wu, Zhiyuan, i dr.
  Izdano: (2014)
• Clonal independence of JAK2 and CALR or MPL mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencing
  od: Thompson, Ella R., i dr.
  Izdano: (2020)